BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Breaking News: Read BioWorld's AACR 2026 coverageBreaking News: Read BioWorld's AACR 2026 coverageBreaking News: Best of BioWorld: Q1
Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
BioWorld Science, Nephrology RSS Feed RSS

Nymox completes enrollment in second re-injection study of NX-1207 for BPH

July 16, 2014

ZS Pharma completes enrollment in second phase III study of ZS-9 in hyperkalemia

July 16, 2014

Takeda plans phase I study of ixazomib citrate in lupus nephritis

July 11, 2014

Humanetics awarded NCI grant to test BIO-300 for radiation-induced erectile dysfunction

July 10, 2014

Kyowa Hakko Kirin to start new phase II study of bardoxolone methyl

July 7, 2014

Quark completes study of QPI-1002 to prevent delayed graft function in kidney transplantation

July 4, 2014

Renal benefits reported for VPI-2690B in a model of diabetic nephropathy

July 4, 2014

CHMP recommends Velphoro for control of serum phosphorus levels in adults with CKD

July 1, 2014

Ischemix enrolls first patient in phase IIa trial to prevent contrast-induced kidney injury

June 30, 2014

Sobi files for E.U. approval of Xiapex for Peyronie's disease

June 26, 2014
Previous 1 2 … 84 85 86 87 88 89 90 91 92 … 328 329 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • Epileptic brain and abnormal EEG wave discharges

    Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest

    BioWorld
    A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
  • Gold-encircled handshake

    Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal

    BioWorld
    The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing